Correlation Between Viking Therapeutics and Opus Genetics,

Can any of the company-specific risk be diversified away by investing in both Viking Therapeutics and Opus Genetics, at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Viking Therapeutics and Opus Genetics, into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Viking Therapeutics and Opus Genetics,, you can compare the effects of market volatilities on Viking Therapeutics and Opus Genetics, and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Viking Therapeutics with a short position of Opus Genetics,. Check out your portfolio center. Please also check ongoing floating volatility patterns of Viking Therapeutics and Opus Genetics,.

Diversification Opportunities for Viking Therapeutics and Opus Genetics,

0.59

Correlation Coefficient

Viking Therapeutics  Opus Genetics,

Very weak diversification

The 3 months correlation between Viking and Opus is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Viking Therapeutics and Opus Genetics, in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Opus Genetics, and Viking Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Viking Therapeutics are associated (or correlated) with Opus Genetics,. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Opus Genetics, has no effect on the direction of Viking Therapeutics i.e., Viking Therapeutics and Opus Genetics, go up and down completely randomly.

Pair Corralation between Viking Therapeutics and Opus Genetics,

Given the investment horizon of 90 days Viking Therapeutics is expected to generate 2.13 times more return on investment than Opus Genetics,. However, Viking Therapeutics is 2.13 times more volatile than Opus Genetics,. It trades about 0.08 of its potential returns per unit of risk. Opus Genetics, is currently generating about -0.05 per unit of risk. If you would invest  1,745  in Viking Therapeutics on September 4, 2024 and sell it today you would earn a total of  3,281  from holding Viking Therapeutics or generate 188.02% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Weak
Accuracy	100.0%
Values	Daily Returns

Viking Therapeutics  vs.  Opus Genetics,

Viking Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Viking Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong basic indicators, Viking Therapeutics is not utilizing all of its potentials. The latest stock price disturbance, may contribute to short-term losses for the investors.

Opus Genetics,

Risk-Adjusted Performance

1 of 100

Very Weak

Compared to the overall equity markets, risk-adjusted returns on investments in Opus Genetics, are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. In spite of rather unfluctuating basic indicators, Opus Genetics, may actually be approaching a critical reversion point that can send shares even higher in January 2025.

Pair Trading with Viking Therapeutics and Opus Genetics,

The main advantage of trading using opposite Viking Therapeutics and Opus Genetics, positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Viking Therapeutics position performs unexpectedly, Opus Genetics, can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Opus Genetics, will offset losses from the drop in Opus Genetics,'s long position.

The idea behind Viking Therapeutics and Opus Genetics, pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.